There has been considerable news about the manufacturer of the EpiPen.
From The NY Times:
“In the meantime, I still believe — perhaps foolishly — that sustained attention might create change. And so, as long as Mylan flouts the norms of good corporate behavior, it seems worth continuing to scrutinize what the company is doing, and questioning why EpiPens cost so much.”
Being in business is not just profits and stock prices….it is also being a good citizen. While Mylan may have a monopoly on the EpiPen and act imprudently….at some point market forces will disrupt inexcusable behavior.